OBJECTIVE: To determine the accuracy of the WatchBP Office ABI monitor for blood pressure measurement developed by the Microlife Company. METHODS: The device accuracy was tested in 85 subjects with a mean age of 54    19 years. Their systolic and diastolic blood pressure ( @entity13519 / @entity13520 ) at entry was 141    30/86    19 mmHg, and upper arm circumference was 28    5 cm. Initially, the data from 33 @entity1 were examined according to the 2002 version of the European Society of @entity101 (ESH) protocol. An additional 52 subjects were then enrolled to fulfill the requirements of the British @entity101 Society (BHS) protocol. In all @entity1 , sequential same arm measurements were performed by two trained observers. RESULTS: The device passed all three phases of the ESH protocol for @entity13519 and @entity13520 . For the BHS protocol the device was graded A for both @entity13519 and @entity13520 . The A/A grade was achieved in the low blood pressure category (< 130/80 mmHg), the B/A grade in the medium category (130-160/80-100 mmHg) and the A/A grade in the high category (> 160/100 mmHg). Mean blood pressure difference between device and observers in the first 33 subjects was -0.9    5.5 mmHg for @entity13519 and -2.2    4.5 mmHg for @entity13520 and in the 85 @entity1 it was -1.2    6.5 mmHg and -2.3    5.1, respectively. CONCLUSION: These data show that the Microlife WatchBP Office ABI monitor satisfied the recommended ESH accuracy levels and achieved A/A grade of the BHS protocol across a wide range of BP.

Accuracy of Microlife WatchBP Office ABI monitor assessed according to the 2002 European Society of XXXX protocol and the British @entity101 Society protocol.

@entity1 :: ('9606', 'Species') :: ['participants'] @entity101 :: ('MESH:D006973', 'Disease') :: ['Hypertension'] @entity13520 :: ('1628', 'Gene') :: ['DBP'] @entity13519 :: ('8991', 'Gene') :: ['SBP']
@entity101 :: (MESH:D006973,Disease) :: ['Hypertension']
